Continuous Treatment Improves Survival of Newly Diagnosed Multiple Myeloma Patients Achieving Complete Response: Data from 5 Phase III Trials Including Young and Elderly Patients

C. Cerrato,F. Gay,M.T. Petrucci, M. Pellegrino,G. Gaidano,M. Offidani,L. el Jarari, T. Gugielmelli, M. Salvini,F. Patriarca,G. Semenzato,S. Zweegman,F. Di Raimondo, R. Mina,N. Cascavilla,D.B. Yehuda,M. Gambella,P. Corradini,H. Lokhorst,L. Catalano

Clinical lymphoma myeloma & leukemia/Clinical lymphoma, myeloma and leukemia（2015）

引用 1|浏览21

暂无评分

摘要

Several studies demonstrated that continuous therapy (CT) prolonged progression-free survival (PFS); conflicting data exist about overall survival (OS) for patients eligible and ineligible for autologous stem cell transplantation (ASCT). CT in patients with a sensitive disease is a matter of debate. We conducted a pooled analysis to clarify the role of CT in patients with a complete response (CR).

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要